USD 0.13
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 167.89 Thousand USD | -26.52% |
2022 | 228.48 Thousand USD | -3.41% |
2021 | 236.55 Thousand USD | 14.67% |
2020 | 206.29 Thousand USD | 20.04% |
2019 | 171.86 Thousand USD | 0.0% |
2014 | -2.69 Million USD | 5.93% |
2013 | -1.62 Million USD | -12563.12% |
2012 | -65.02 Thousand USD | 79.71% |
2011 | -43.74 Thousand USD | -70.85% |
2010 | -63.23 Thousand USD | -80.4% |
2009 | -37 Thousand USD | -299.51% |
2008 | 5729.00 USD | 76.97% |
2007 | -5135.00 USD | -145.46% |
2006 | -22.29 Thousand USD | 0.0% |
1997 | -3.2 Million USD | 23.81% |
1996 | -3.2 Million USD | -90.91% |
1995 | -2.2 Million USD | -83.33% |
1994 | -1.2 Million USD | -71.43% |
1993 | -700 Thousand USD | -40.0% |
1992 | -500 Thousand USD | -600.0% |
1991 | 100 Thousand USD | 0.0% |
1990 | 100 Thousand USD | 200.0% |
1989 | -100 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q1 | 41.58 Thousand USD | 0.0% |
2023 FY | - USD | -26.52% |
2022 FY | - USD | -3.41% |
2021 Q1 | - USD | 0.0% |
2021 FY | - USD | 14.67% |
2021 Q2 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | - USD | 20.04% |
2020 Q1 | - USD | 0.0% |
2019 FY | - USD | 0.0% |
2015 Q1 | -504.8 Thousand USD | -2.3% |
2015 Q2 | -369.78 Thousand USD | 26.75% |
2014 FY | - USD | 5.93% |
2014 Q4 | -493.45 Thousand USD | -58.71% |
2014 Q1 | -498.42 Thousand USD | -13.75% |
2014 Q2 | -225.23 Thousand USD | 54.81% |
2014 Q3 | -310.91 Thousand USD | -38.04% |
2013 Q3 | -48.69 Thousand USD | -5.77% |
2013 Q4 | -438.19 Thousand USD | -799.82% |
2013 Q1 | -48.03 Thousand USD | -1579.69% |
2013 Q2 | -46.04 Thousand USD | 4.15% |
2013 FY | - USD | -12563.12% |
2012 Q4 | -2860.00 USD | 3.38% |
2012 FY | - USD | 79.71% |
2012 Q1 | -3956.00 USD | -134.02% |
2012 Q3 | -2960.00 USD | 74.94% |
2012 Q2 | -11.81 Thousand USD | -198.58% |
2011 Q2 | -9207.00 USD | 57.32% |
2011 Q4 | 11.63 Thousand USD | 202.97% |
2011 FY | - USD | -70.85% |
2011 Q1 | -21.57 Thousand USD | -445.35% |
2011 Q3 | -11.29 Thousand USD | -22.68% |
2010 Q4 | -3956.00 USD | 38.78% |
2010 Q2 | -31.23 Thousand USD | -46.11% |
2010 Q3 | -6462.00 USD | 79.31% |
2010 Q1 | -21.38 Thousand USD | -2.18% |
2010 FY | - USD | -80.4% |
2009 FY | - USD | -299.51% |
2009 Q3 | 7104.00 USD | 492.49% |
2009 Q2 | -1810.00 USD | -104.66% |
2009 Q1 | 38.8 Thousand USD | 2509.94% |
2009 Q4 | -20.92 Thousand USD | -394.52% |
2008 Q1 | -1137.00 USD | -32.52% |
2008 FY | - USD | 76.97% |
2008 Q4 | -1610.00 USD | 97.06% |
2008 Q3 | -54.84 Thousand USD | -1644.89% |
2008 Q2 | -3143.00 USD | -176.43% |
2007 Q1 | -1140.00 USD | 90.19% |
2007 Q2 | -2313.00 USD | -102.89% |
2007 Q4 | -858.00 USD | -3.75% |
2007 Q3 | -827.00 USD | 64.25% |
2007 FY | - USD | -145.46% |
2006 FY | - USD | 0.0% |
2006 Q4 | -11.61 Thousand USD | -45.64% |
2006 Q3 | -7976.00 USD | -409.32% |
2006 Q1 | -6723.00 USD | -1263.69% |
2006 Q2 | -1566.00 USD | 76.71% |
2005 Q4 | -493.00 USD | 59.52% |
2005 Q3 | -1218.00 USD | 0.0% |
1997 Q2 | -2.7 Million USD | 77.31% |
1997 Q3 | -800 Thousand USD | 70.37% |
1997 Q1 | -9.1 Million USD | -4066.67% |
1997 FY | - USD | 23.81% |
1996 Q2 | -1.8 Million USD | 578.95% |
1996 Q3 | -2.7 Million USD | -109.89% |
1996 Q4 | -1.7 Million USD | 133.33% |
1996 FY | - USD | -90.91% |
1996 Q1 | -3.1 Million USD | -137.5% |
1995 Q4 | -800 Thousand USD | 11.11% |
1995 FY | - USD | -83.33% |
1995 Q3 | -900 Thousand USD | -80.0% |
1995 Q2 | -500 Thousand USD | 16.67% |
1995 Q1 | -600 Thousand USD | -20.0% |
1994 Q4 | -600 Thousand USD | 44.44% |
1994 Q3 | -800 Thousand USD | -80.0% |
1994 Q2 | -500 Thousand USD | 73.68% |
1994 FY | - USD | -71.43% |
1994 Q1 | -1.9 Million USD | -733.33% |
1993 FY | - USD | -40.0% |
1993 Q4 | 300 Thousand USD | -72.73% |
1993 Q3 | 1.1 Million USD | 1200.0% |
1993 Q2 | -100 Thousand USD | 0.0% |
1993 Q1 | -100 Thousand USD | 75.0% |
1992 Q2 | 400 Thousand USD | 119.05% |
1992 Q4 | -200 Thousand USD | -300.0% |
1992 Q3 | -100 Thousand USD | -125.0% |
1992 Q1 | -2.1 Million USD | -625.0% |
1992 FY | - USD | -600.0% |
1991 Q2 | 500 Thousand USD | 266.67% |
1991 Q1 | -300 Thousand USD | -400.0% |
1991 Q4 | 400 Thousand USD | -42.86% |
1991 Q3 | 700 Thousand USD | 40.0% |
1991 FY | - USD | 0.0% |
1990 Q3 | 100 Thousand USD | 0.0% |
1990 Q1 | -100 Thousand USD | -200.0% |
1990 FY | - USD | 200.0% |
1990 Q4 | 100 Thousand USD | 0.0% |
1990 Q2 | 100 Thousand USD | 200.0% |
1989 Q3 | 100 Thousand USD | 0.0% |
1989 Q4 | 100 Thousand USD | 0.0% |
1989 FY | - USD | 0.0% |
1989 Q1 | -300 Thousand USD | -400.0% |
1989 Q2 | 100 Thousand USD | 133.33% |
Name | EBITDA | EBITDA Difference |
---|---|---|
The Amacore Group, Inc. | -10.98 Million USD | 101.529% |
Arem Pacific Corporation | 36.71 Thousand USD | -357.293% |
Assisted 4 Living, Inc. | -112.91 Thousand USD | 248.697% |
BioCorRx Inc. | -2.68 Million USD | 106.256% |
Bionik Laboratories Corp. | -4.77 Million USD | 103.516% |
Banyan Corp. | 583.94 Thousand USD | 71.248% |
Clearday, Inc. | -7.53 Million USD | 102.228% |
Dental Patient Care America, Inc. | 12.87 Thousand USD | -1204.241% |
Quantum Medical Transport, Inc. | - USD | -Infinity% |
Empower Clinics Inc. | -1.08 Million USD | 115.428% |
First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 107.598% |
Selectis Health, Inc. | -7.29 Million USD | 102.302% |
Ethema Health Corporation | 2.07 Million USD | 91.898% |
HealthLynked Corp. | -2.75 Million USD | 106.105% |
HQDA Elderly Life Network Corp. | - USD | -Infinity% |
Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 106.325% |
JRSIS Health Care Corporation | 28.84 Thousand USD | -482.039% |
Medical Facilities Corporation | 77.94 Million USD | 99.785% |
MedSmart Group Inc. | 47.8 Thousand USD | -251.179% |
North America Frac Sand, Inc. | -623.33 Thousand USD | 126.935% |
Nova Leap Health Corp. | 994.46 Thousand USD | 83.117% |
Nexteligent Holdings, Inc. | -201.73 Thousand USD | 183.228% |
PAO Group, Inc. | 292.96 Thousand USD | 42.691% |
Primemd Inc. | 3.42 Million USD | 95.101% |
Raffles Medical Group Ltd | 100.7 Million USD | 99.833% |
Ryman Healthcare Limited | -54.51 Million USD | 100.308% |
Stem Cell Authority, Ltd. | -4233.00 USD | 4066.336% |
SETO Holdings, Inc. | - USD | -Infinity% |
Optima Medical Innovations Corp. | -2.89 Million USD | 105.801% |
Mycotopia Therapies, Inc. | -555.5 Thousand USD | 130.224% |
U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 442.643% |
Veltex Corporation | -938.45 Thousand USD | 117.891% |
World Financial Holding Group | -28.43 Thousand USD | 690.556% |
Xcelerate Inc. | -2.53 Million USD | 106.614% |